Should MARA Stock Be in Your Portfolio Pre-Q2 Earnings?
The Zacks Consensus Estimate for the bottom line is pegged at a loss of 49 cents per share compared with a loss of 24 cents in the year-ago quarter. The consensus mark for revenues is pinned at $228.9 million, indicating 57.7% year-over-year growth.
Earnings surpassed the Zacks Consensus Estimate in one of the past four quarters, matched once and missed in the other two, delivering an average surprise of 136.1%. The bottom-line estimate has remained unchanged in the past 30 days.
Bleak Chances of an Earnings Beat for MARA
Our proven model doesn't conclusively predict an earnings beat for RIOT this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that's not the case here. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.
MARA has an Earnings ESP of 0.00% and a Zacks Rank #3. You can see the complete list of today's Zacks #1 Rank stocks here.
Dual Approach Should Boost MARA's Revenues
MARA's top line in the to-be-reported quarter is likely to have benefited from the company's dual approach to Bitcoin mining, combining revenue generation with strategic asset accumulation. By leveraging its expansive and energy-efficient mining operations, it produces Bitcoin at lower costs, ensuring consistent revenue streams. MARA retains a significant portion of the Bitcoin it mines, positioning itself to capitalize on potential price appreciation over time.
MARA's Price Dynamics
The stock has gained 21% over the past three months. Over this period, MARA's competitors in the bitcoin-mining space, such as Riot Platforms, Inc. RIOT and HuT 8 Corp. HUT have gained 96% and 56%, respectively.
Marathon Digital Holdings, Inc. Price and EPS Surprise
Marathon Digital Holdings, Inc. price-eps-surprise | Marathon Digital Holdings, Inc. Quote
Pre-Earnings Investment Considerations
MARA remains a cautious hold amid a mixed performance landscape. Its strategic expansion through increased mining capacity and cost-effective facility acquisitions supports long-term growth. Additionally, the prospect of a crypto-friendly regulatory environment is likely to have provided a favorable tailwind for the company. Although its revenue generation appears robust, near-term profitability continues to face challenges. The firm's balanced approach of combining immediate income with strategic asset accumulation suggests that investors should hold their positions while awaiting operational improvements and a supportive market backdrop.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Marathon Digital Holdings, Inc. (MARA) : Free Stock Analysis Report
Riot Platforms, Inc. (RIOT) : Free Stock Analysis Report
Hut 8 Corp. (HUT) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
CareTrust REIT (CTRE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, CareTrust REIT (CTRE) reported revenue of $112.47 million, up 63.3% over the same period last year. EPS came in at $0.43, compared to $0.07 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $107.52 million, representing a surprise of +4.6%. The company delivered an EPS surprise of -4.44%, with the consensus EPS estimate being $0.45. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how CareTrust REIT performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Rental income: $86.03 million versus $75.75 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +55.3% change. Revenues- Interest income from other real estate related investments and other income: $23.55 million versus $25.05 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +74.7% change. Net Earnings Per Share (Diluted): $0.35 compared to the $0.36 average estimate based on two analysts. View all Key Company Metrics for CareTrust REIT here>>> Shares of CareTrust REIT have returned +6% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CareTrust REIT, Inc. (CTRE) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
2 hours ago
- Yahoo
Sarepta Therapeutics (SRPT) Reports Q2 Earnings: What Key Metrics Have to Say
Sarepta Therapeutics (SRPT) reported $611.09 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 68.4%. EPS of $2.02 for the same period compares to $0.07 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $529.54 million, representing a surprise of +15.4%. The company delivered an EPS surprise of +81.98%, with the consensus EPS estimate being $1.11. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Sarepta Therapeutics performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Product, net: $513.12 million versus $506.99 million estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +42.3% change. Revenues- PMO Products: $231.27 million versus the seven-analyst average estimate of $228.28 million. Revenues- Collaboration: $97.97 million compared to the $21.79 million average estimate based on seven analysts. The reported number represents a change of +4011.1% year over year. Revenues- Product, net- ELEVIDYS: $281.85 million versus the seven-analyst average estimate of $277.86 million. The reported number represents a year-over-year change of +131.6%. View all Key Company Metrics for Sarepta Therapeutics here>>> Shares of Sarepta Therapeutics have returned -12% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sarepta Therapeutics, Inc. (SRPT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
2 hours ago
- Yahoo
Trump announces 100% tariffs on chips, mining stocks tumble
Trump announces 100% tariffs on chips, mining stocks tumble originally appeared on TheStreet. President Donald Trump announced on Aug. 6 that he will impose tariffs as high as 100% on imports of chips and semiconductors to the U.S. Only those manufacturing these products in the U.S. can escape this charge, he added. Trump told reporters in the Oval Office that the new rate would apply to all chip and semiconductor imports except those from companies that have committed to manufacturing in the U.S. As reported earlier, the Bitcoin mining industry has taken a hit due to Trump's tariffs on chips. Mining is the process of using high-tech hardware to validate and secure transactions on a blockchain network that forms the infrastructure of the crypto industry. While the U.S. is the world leader among crypto mining countries, it is Asian countries such as China, Indonesia, Malaysia, and Thailand that are the key manufacturers of mining rig equipment on which even the miners based in the U.S. are announcement immediately sent shockwaves through the stocks of nearly all crypto mining companies. MARA Holdings (Nasdaq: MARA), a prominent Bitcoin miner based in Florida, fell 0.13% in after hours to $15.87 at the time of writing. Similarly, the Colorado-headquartered Riot Platforms (Nasdaq: RIOT) dropped 0.69% to $11.58. Singapore-headquartered miner Bitdeer Technologies (Nasdaq: BTDR) fell 0.62% to $12.89, and the Henderson, Nevada-headquartered CleanSpark, Inc. (Nasdaq: CLSK) fell 0.18% to $10.98. HIVE Digital Technologies (Nasdaq: HIVE) also fell 0.94% to $2.10. Hut 8 (Nasdaq: HUT) fell 0.19% to $20.65. The total crypto market cap stood at $3.76 trillion at the time of writing. Trump announces 100% tariffs on chips, mining stocks tumble first appeared on TheStreet on Aug 6, 2025 This story was originally reported by TheStreet on Aug 6, 2025, where it first appeared. Sign in to access your portfolio
